Keywords: roche, ups, royalties, amgen, bid, get, mircera

Roche ups royalties to Amgen in bid to get Mircera on US market

Article | 24 March 2008

Print This

Swiss drug major Roche has offered to pay higher royalties of 22.5% (versus 20%) to US biotechnology giant Amgen in order to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in